Teva-Fulvestrant Injection 50 mg

Teva-Fulvestrant Injection 50 mg is a prescription medication used for hormone receptor-positive breast cancer treatment. This intramuscular solution is manufactured by Teva Canada Limited and is available in 2x5ml packs.

Fulvestrant is a type of hormone therapy used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It works by blocking the effects of estrogen in the body, which can help slow or stop the growth of certain types of breast cancer cells. This medication is typically used in cases where the cancer has spread to other parts of the body or has returned after initial treatment.

Common effects of Fulvestrant may include injection site reactions, such as pain, swelling, or redness. Some individuals may also experience hot flashes, nausea, or headache. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Fulvestrant should be used with caution in individuals with a history of liver or kidney problems. It is important to inform your healthcare provider about any other medications you are taking, as well as any allergies or medical conditions you have. This medication should be administered by a healthcare professional to ensure proper dosage and minimize the risk of side effects.

Fulvestrant may interact with other medications, including those that are metabolized by the liver. It is important to inform your healthcare provider about all medications you are taking, including prescription and over-the-counter drugs, vitamins, and herbal supplements. Alcohol consumption should be avoided while using this medication, as it may increase the risk of side effects.